Quantitative Structure-Activity Relationship Study Of Volitinib And Its Derivatives As A Highly Potent And Selective Mesenchymal-Epithelial Transition Factor (c-Met) Inhibitor
Cancer is the one of the incurable diseases which causing the tragically death among the developing country. Many research and therapy have been uses for the treatment of this cancer disease. The main factor of the cause of cancer is the growth of cancer cells or the tumor which cannot be prevent....
Saved in:
Main Author: | Rifdi Bin Mohamad Fuzi, Mohamad |
---|---|
Format: | Final Project |
Language: | Indonesia |
Online Access: | https://digilib.itb.ac.id/gdl/view/44755 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Institut Teknologi Bandung |
Language: | Indonesia |
Similar Items
-
Investigating functions of ERp29 in mesenchymal to epithelial transition (MET) and epithelial plasticity in breast cancer cells
by: I FON BAMBANG
Published: (2012) -
Induction of mesenchymal-epithelial transition (MET) by epigallocatechin-3-gallate to reverse epithelial-mesenchymal transition (EMT) in SNAI1-overexpressed renal cells: A potential anti-fibrotic strategy
by: Rattiyaporn Kanlaya, et al.
Published: (2022) -
Induction of mesenchymal-epithelial transition (MET) by epigallocatechin-3-gallate to reverse epithelial-mesenchymal transition (EMT) in SNAI1-overexpressed renal cells: A potential anti-fibrotic strategy
by: Kanlaya R.
Published: (2023) -
Epithelial-Mesenchymal Transitions in Development and Disease
by: Thiery, J.P., et al.
Published: (2014) -
The role of N-WASP in epithelial-to-mesenchymal transition.
by: Muhammad Hakimullah Mohamed Ikbar.
Published: (2013)